Maryjane Farr joined the UT Southwestern Medical Center in 2021 as Professor of Medicine, Section Chief of Heart Failure, Mechanical Circulatory Support and Transplant, and holds the Jackie and Charles Solomon Distinguished Chair in Clinical Excellence. Previously she was the Irene and Sidney B. Silverman Associate Professor of Medicine and Medical Director of the Adult Heart Transplant Program at Columbia University Irving Medical Center. Dr. Farr is a graduate of Barnard College, Columbia University (BA 89), Columbia College of Physicians & Surgeons, AOA (MD 98) and the Columbia Mailman School of Public Health (MSc 12). Dr. Farr trained in Internal Medicine, Cardiovascular Diseases and Advanced Heart Failure and Transplant at the New York Presbyterian Hospital and joined the staff in 2005. Dr. Farr was Director of Clinical Trials in Heart Failure and Transplant at Columbia from 2007-12, received an NIH training grant for her Masters degree from 2010-12 and was awarded the Shorin Silverstein Research in Transplant Award (at Columbia) for 2012-14. Dr. Farr directed the Columbia Adult Heart Transplant Program for 6 years, and during her 14 years on the team participated in the management of nearly 1000 new heart transplant recipients. She has authored more than 100 peer-reviewed manuscripts in the field of heart failure, mechanical circulatory support, and transplant. She has participated in scholarly work and education with the ACC, AHA, HFSA, ISHLT, and AST. She has been an active member and leader at UNOS/OPTN on the Thoracic Committee, as Heart Subcommittee Chair, on the Membership and Professional Standards Committee, as Region 9 (New York) Associate Councilor, and was recently appointed to the UNOS/OPTN Board of Directors for a 3 year term. She is the Chair of the Conflict of Interest Committee for the ISHLT and she is an Associate Editor of Transplantation and Content Editor at Circulation. Her key areas of interest are organ allocation, primary graft failure, cardiogenic shock, complications of mechanical circulatory support as bridge to transplant, and overall survival of patients with advanced heart failure.